Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

H4. HIV: Treatment

Poster Session: HIV: Treatment

(P-565) A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Co-Author(s)

  • Princy N. Kumar, MD

    Chief, Division of Infectious Diseases
    Georgetown University Medical Center
    Washington, District of Columbia, United States

    • Presenting Author(s)

  • CR

    Charlotte-Paige M. Rolle, MD, MPH (she/her/hers)

    Director of Research Operations; Adjunct Assistant Professor of Global Health
    Orlando Immunology Center; Emory Rollins School of Public Health
    Orlando, Florida, United States

    • Co-Author(s)

  • BE

    Brinda Emu, MD

    Associate Professor of Medicine
    Yale University
    New Haven, CT, United States

  • ZH

    Zachary Henry, MD

    AHF Northpoint Healthcare Center
    Fort Lauderdale, Florida, United States

  • CM

    Claudia Martorell, MD

    The Research Institute
    springfield, Massachusetts, United States

  • JM

    John E. McKinnon, MD, MSc

    Associate Professor of Medicine
    Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina,
    Charleston, South Carolina, United States

  • Jihad Slim, MD, FACP

    Medical Director
    Saint Michael’s Medical Center, Newark, NJ, USA
    Newark, New Jersey, United States

  • R Brandon Cash, PharmD

    Vice President Global Medical Affairs
    Theratechnologies, Inc
    Montreal, Quebec, Canada

    • Co-Author(s)

  • KA

    Kaitlin Anstett, PhD (She/they)

    Associate Medical Director, Virology
    Theratechnologies Inc., Canada